Vancouver’s Miraterra has taken a major step forward in agricultural technology by acquiring the assets of California-based Trace Genomics. The deal includes Trace’s intellectual property, commercial products, and a state-of-the-art soil analysis laboratory in Ames, Iowa.
This strategic move brings together Miraterra’s expertise in Raman spectroscopy—a rapid, non-invasive method for analyzing soil, plants, and food—with Trace Genomics’ pioneering DNA-based soil testing platform. By integrating these technologies, Miraterra aims to deliver comprehensive, accessible, and affordable soil-to-table measurement solutions that benefit growers, researchers, and the entire food supply chain.
Trace Genomics, founded in the Bay Area, is recognized for its innovative approach to decoding soil biology, enabling farmers and agronomists to better understand the microbiome beneath their crops and make data-driven decisions for improved yield and sustainability. With this acquisition, Miraterra enhances its ability to offer a full spectrum of soil diagnostics, combining biological, mineral, and hydrological insights.
The acquisition also includes Trace’s advanced laboratory and technical team in Ames, Iowa, which will remain central to Miraterra’s expanded operations. This ensures continuity for existing Trace customers and positions the company to serve new markets with even greater measurement capabilities.
Miraterra’s expanded platform is set to accelerate the adoption of next-generation soil health diagnostics, supporting productivity, sustainability, and collaboration across the agricultural sector. As the company grows, it continues to reinforce Ames’ reputation as a hub for agtech innovation, research, and high-quality job creation.
With this acquisition, Miraterra is poised to lead the way in integrated soil, plant, and food analytics—delivering actionable insights that help shape the future of sustainable agriculture.
